Our Products

Information on Eisai’s products contained in this website consist of a true reproduction of the product’s package insert approved by ANVISA, therefore, may present variations as to the package insert approved in other countries. The use of drugs without medical guidance can lead to health risks, therefore, always seek the advice of a physician before using any of Eisai’s products.

HALAVEN® (eribulin mesylate) Injection

LENVIMA® (lenvatinib mesylate) 4 mg and 10 mg - capsules